Global Radiodermatitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431622
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • Acelity
  • Alliqua Biomedical
  • BMG Pharma S.R.L.
  • Convatec, Inc.
  • Derma Sciences, Inc.
  • MORE
Radiodermatitis Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global radiodermatitis market was valued at US$ 295.5 Mn in 2016, and is expected to reach US$ 430.9 Mn by 2025 expanding at a CAGR of 4.18% from 2017 to 2025.

Market Insights

As per the report published in the European Oncology Nursing Socitey, 2016 as many as 95% of oncology patients opting radiation therapy will experience some degree of reaction on their skin due to radiation therapy. Currently no evidence supports of any medication present to prevent radiodermatitis. Some general guidelines have been considered for the effective management of radiodermatitis in oncology patients previously undergone radiation therapy such as gentle washing and drying, topical moisturizers should be applied before radiation therapy. Additionally usual hygiene practices must be followed such as use of mild detergent, deodorants not to be used on the exposed area, and smoking should be avoided.

In 2016, topical segment held the largest market share due to key drivers such as corticosteroids are considered as the gold standard for the treatment of radiodermatitis and the increasing demand for the hydrophilic creams which have been effective in overcoming the patients discomfort by providing moisture to the dry desquamation skin area. Dressings will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as increasing oncology patients opting for radiation therapy, wide spectrum of dressings available as per the degree of skin complication due to radiation therapy. The technological advancement with the hydrocolloid and hydrogel dressings are finding tremendous applications as they are used for the management of moist desquamation in order to promote a moist environment to facilitate reepithelization.

In 2016, North America held the largest revenue share mainly due to factors such as rising prevalence of radiodermatitis, affordable reimbursement scenario and existence of developed research and healthcare institutions. Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as rising prevalence of radiodermatitis, competitive market due to presence of existing and budding manufacturers involved in the palliative treatment of radiodermatitis, increasing disposable incomes in these regions and flourishing online market for the sale of medication for radiodermatitis treatment.

Key Market Movements:
  • Rising demand for radiation therapy among the oncology patients
  • Merger and acquisition between healthcare industries has resulted in the expansion of product portfolio for radiodermatitis treatment
  • Supportive regulatory environment for radiodermatitis drugs
  • Affordable reimbursement scenario for the treatment of radiodermatitis in developed countries
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • Acelity
  • Alliqua Biomedical
  • BMG Pharma S.R.L.
  • Convatec, Inc.
  • Derma Sciences, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Radiodermatitis Market Portraiture
2.1.1. Global Radiodermatitis Market, by Product, 2016
2.1.2. Global Radiodermatitis Market, by Geography, 2016

Chapter 3. Global Radiodermatitis Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Radiodermatitis Market, by Product
4.3. Topical
4.3.1. Antibiotics
4.3.2. Hydrophilic Creams
4.3.3. Corticosteroids
4.3.4. Others
4.4. Dressing
4.4.1. No String Barrier Films
4.4.2. Honey Impregnated Gauze
4.4.3. Hydrogel and Hydrocolloid Dressings
4.4.4. Silicone Coated Dressings
4.4.5. Others
4.5. Oral

Chapter 5. Global Radiodermatitis Market, by Geography, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. North America Radiodermatitis Market Analysis, 2015 - 2025
5.2.1. North America Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
5.2.2. North America Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Radiodermatitis Market Analysis, 2015 - 2025
5.3.1. Europe Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
5.3.2. Europe Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Radiodermatitis Market Analysis, 2015 - 2025
5.4.1. Asia Pacific Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
5.4.2. Asia Pacific Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. India
5.4.2.4. Rest of APAC
5.5. Latin America Radiodermatitis Market Analysis, 2015 - 2025
5.5.1. Latin America Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
5.5.2. Latin America Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Radiodermatitis Market Analysis, 2015 - 2025
5.6.1. MEA Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
5.6.2. MEA Radiodermatitis Market, by Region, 2015 - 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Acelity
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Alliqua Biomedical
6.3. BMG Pharma S.R.L.
6.4. Convatec, Inc.
6.5. Derma Sciences, Inc.
6.6. Intermed Pharmaceuticals
6.7. Molnlycke Health Care AB
6.8. Smith & Nephew plc
6.9. Stratpharma AG
6.10. 3M Healthcare
6.11. Other Notable Players

List of Figures
Fig. 1 Radiodermatitis: Market Segmentation
Fig. 2 Global Radiodermatitis Market Share, by Product, 2016 (Value %)
Fig. 3 Global Radiodermatitis Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition, by Geography
Fig. 5 Market Competition Landscape, by Key Players, 2016
Fig. 6 Global Topical Market, 2015 - 2025 (US$ Mn)
Fig. 7 Global Antibiotics Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Hydrophilic Creams Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Corticosteroids Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Others Topical Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Dressing Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global No String Barrier Films Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Honey Impregnated Gauze Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Hydrogel and Hydrocolloid Dressings Market, 2015 - 2025 (US$ Mn)
Fig. 15 Global Silicone Coated Market, 2015 - 2025 (US$ Mn)
Fig. 16 Global Others Dressing Market, 2015 - 2025 (US$ Mn)
Fig. 17 Global Oral Market, 2015 - 2025 (US$ Mn)
Fig. 18 U.S. Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 19 Canada Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 20 U.K. Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 21 Germany Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 22 Rest of Europe Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 23 Japan Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 24 China Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 25 India Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 26 Rest of Asia Pacific Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 27 Brazil Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 28 Mexico Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 29 Rest of Latin America Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 30 GCC Radiodermatitis Market, 2015 - 2025 (US$ Mn)
Fig. 31 Rest of Middle East and Africa Radiodermatitis Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 2 Global Radiodermatitis Market, by Geography, 2015 - 2025 (US$ Mn)
Table 3 North America Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 4 North America Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Europe Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 6 Europe Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Asia Pacific Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 8 Asia Pacific Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Latin America Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 10 Latin America Radiodermatitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 11 Middle East and Africa Radiodermatitis Market, by Product, 2015 - 2025 (US$ Mn)
Table 12 Middle East and Africa Radiodermatitis Market, by Region, 2015 - 2025 (US$ Mn)
Table 13 Acelity: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 14 Alliqua Biomedical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 15 BMG Pharma S.R.L.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 16 Convatec, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 17 Derma Sciences, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 18 Intermed Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 19 Molnlycke Health Care AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 20 Smith & Nephew plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 21 Stratpharma AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 22 3M Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Acelity
  • Alliqua Biomedical
  • BMG Pharma S.R.L.
  • Convatec, Inc.
  • Derma Sciences, Inc.
  • Intermed Pharmaceuticals
  • Molnlycke Health Care AB
  • Smith & Nephew plc
  • Stratpharma AG
  • 3M Healthcare
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll